New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.
May 28, 2025
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.